Topic Hub
13 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 13 of 13 clinical reviews.
How common diarrhea actually is on Wegovy, who gets it, how severe it tends to be, and what the STEP trial data shows about resolution timelines.
Read clinical reviewA clinically detailed, week-by-week breakdown of diarrhea during Wegovy therapy, covering onset, peak, resolution, and the STEP trial data behind each phase, plus actionable management steps.
Read clinical reviewEvidence-based dietary, hydration, meal-timing, and supplement strategies to reduce diarrhea caused by Wegovy (semaglutide 2.4 mg), with specific foods to favor or avoid.
Read clinical reviewA clinician-tested protocol for assessing, treating, and escalating diarrhea caused by Wegovy (semaglutide 2.4 mg), with trial-backed timelines and clear decision points.
Read clinical reviewOTC and prescription options for treating diarrhea caused by Wegovy (semaglutide 2.4 mg), including loperamide dosing, prescription alternatives, drug interactions to avoid, and when to escalate care.
Read clinical reviewEvidence-based review of supplements that may reduce diarrhea caused by Wegovy (semaglutide 2.4 mg), including probiotics, psyllium, zinc, and glutamine, with dosing guidance and clinical trial data.
Read clinical reviewClinical protocols for adjusting Wegovy dose titration to manage diarrhea, including slowed schedules, dose step-downs, pauses, and microdosing strategies with trial-backed evidence.
Read clinical reviewEvidence-based diet strategies to manage diarrhea caused by Wegovy (semaglutide 2.4 mg), including foods to eat, foods to avoid, and when to call your doctor.
Read clinical reviewLearn when diarrhea from Wegovy (semaglutide 2.4 mg) requires medical attention, why it happens, how long it lasts, and evidence-based strategies to manage this common GLP-1 side effect.
Read clinical reviewA clinical grading rubric for diarrhea caused by Wegovy (semaglutide 2.4 mg), including CTCAE grades, management strategies, and when to contact your prescriber.
Read clinical reviewExplore why Wegovy (semaglutide 2.4 mg) causes diarrhea, how to manage it, and which GLP-1 and non-GLP-1 weight-loss alternatives carry a lower risk of this gastrointestinal side effect.
Read clinical reviewA clinician-reviewed explanation of the GLP-1 receptor mechanisms, gut motility changes, bile acid shifts, and microbiome alterations that cause diarrhea during Wegovy (semaglutide 2.4 mg) treatment.
Read clinical reviewA clinical-grade breakdown of how semaglutide 2.4 mg alters gut motility, delays gastric emptying, shifts bile acid metabolism, and disrupts the gut microbiome to produce diarrhea, plus what you can do about it.
Read clinical review